Takeda pledges support to HAE patients through its Sunrise patient support program
Mumbai, 10th May 2023: Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Pvt. Ltd.), a global values-based, R&D-driven biopharmaceutical leader has launched its ‘Sunrise Patient Services Program (PSP)’ for Hereditary Angioedema (HAE) patients in India. HAE is a life-threatening rare genetic disease that affects various parts of the body, such as limbs, […]
Takeda pledges support to HAE patients through its Sunrise patient support program Read More »